TODESCHINI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 2.193
EU - Europa 1.012
AS - Asia 860
SA - Sud America 143
AF - Africa 12
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 4.227
Nazione #
US - Stati Uniti d'America 2.159
PL - Polonia 357
CN - Cina 306
SG - Singapore 256
UA - Ucraina 151
DE - Germania 132
BR - Brasile 127
IT - Italia 114
HK - Hong Kong 112
FI - Finlandia 74
VN - Vietnam 56
GB - Regno Unito 51
TR - Turchia 35
RU - Federazione Russa 29
IE - Irlanda 28
CA - Canada 23
IN - India 20
FR - Francia 15
SE - Svezia 14
BD - Bangladesh 12
ID - Indonesia 11
IQ - Iraq 9
NL - Olanda 9
ES - Italia 8
MX - Messico 8
AR - Argentina 6
JP - Giappone 6
LT - Lituania 6
BE - Belgio 5
CZ - Repubblica Ceca 5
ZA - Sudafrica 5
KR - Corea 4
SA - Arabia Saudita 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BG - Bulgaria 3
KG - Kirghizistan 3
LU - Lussemburgo 3
MA - Marocco 3
UZ - Uzbekistan 3
AU - Australia 2
CL - Cile 2
CO - Colombia 2
EC - Ecuador 2
EU - Europa 2
IR - Iran 2
KZ - Kazakistan 2
LK - Sri Lanka 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AQ - Antartide 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
DZ - Algeria 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
TO - Tonga 1
VE - Venezuela 1
Totale 4.227
Città #
Warsaw 357
Fairfield 248
Ashburn 210
Woodbridge 178
Singapore 136
Houston 126
Seattle 118
Jacksonville 102
Ann Arbor 99
Chandler 94
Hong Kong 94
Cambridge 87
New York 86
Wilmington 86
Beijing 59
Dearborn 59
Los Angeles 56
Princeton 48
Helsinki 43
Nanjing 31
Brescia 30
Istanbul 29
Dublin 28
Munich 25
Shanghai 25
Indianapolis 21
Jinan 18
San Francisco 18
São Paulo 17
The Dalles 17
Dong Ket 16
Des Moines 15
Chicago 14
Moscow 14
Buffalo 13
Central 13
Hangzhou 13
Hanoi 13
London 13
Denver 12
Ho Chi Minh City 12
Milan 12
Turku 12
Shenyang 11
Toronto 11
Hebei 10
Jiaxing 10
Kunming 10
Santa Clara 10
Dallas 9
Redondo Beach 9
Changsha 8
Montreal 8
San Diego 8
Belo Horizonte 7
Chennai 7
Lanzhou 7
Nanchang 7
Boston 6
Brooklyn 6
Monmouth Junction 6
Orem 6
Phoenix 6
Stockholm 6
Tianjin 6
Brussels 5
Charlotte 5
Jakarta 5
Leawood 5
Ningbo 5
Nuremberg 5
Rome 5
Tokyo 5
Amsterdam 4
Atlanta 4
Biên Hòa 4
Cazzago San Martino 4
Falkenstein 4
Guangzhou 4
Guarulhos 4
Hefei 4
Manchester 4
Miami 4
Nardò 4
Ankara 3
Arezzo 3
Baghdad 3
Bishkek 3
Erbil 3
Espoo 3
Johannesburg 3
Jundiaí 3
Kilburn 3
Luxembourg 3
Mumbai 3
North 3
Norwalk 3
Olomouc 3
Paris 3
Poplar 3
Totale 3.023
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 326
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 311
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 264
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 196
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 180
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor 180
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas 179
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 174
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 172
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 170
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 166
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 162
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 161
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody 153
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 147
Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin. 141
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor 139
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 123
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 122
EXPRESSION PATTERN AND MOLECULAR FUNCTION OF TRASCRIPTION FACTOR FOXM1 (FORKHEAD BOX PROTEIN M1) IN EPITHELIAL OVARIAN CANCER CLINICAL SPECIMENS AND CELL LINES 116
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 116
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 99
Integrated mutational landscape analysis of uterine leiomyosarcomas 95
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 90
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 88
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 62
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 61
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 56
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 54
Totale 4.303
Categoria #
all - tutte 18.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.805


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021351 0 0 0 0 0 46 35 57 46 89 48 30
2021/2022274 38 53 2 4 1 13 21 12 10 44 27 49
2022/2023292 48 15 13 13 25 53 5 31 53 2 17 17
2023/2024386 21 12 42 23 20 96 20 26 64 22 9 31
2024/2025556 6 12 6 83 37 69 29 22 55 36 128 73
2025/2026828 155 134 98 248 182 11 0 0 0 0 0 0
Totale 4.303